Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.

The chemistry of gold nanoparticles (AuNPs) facilitates surface modifications and thus these bioengineered NPs have been investigated as a means of delivering a variety of therapeutic cargos to treat cancer. In this study we have developed AuNPs conjugated with targeting ligands to enhance cell-specific uptake in prostate cancer cells, with a purpose of providing efficient non-viral gene delivery systems in the treatment of prostate cancer. As a consequence, two novel AuNPs were synthesised namely AuNPs-PEG-Tf (negatively charged AuNPs with the transferrin targeting ligands) and AuNPs-PEI-FA (positively charged AuNPs with the folate-receptor targeting ligands). Both bioconjugated AuNPs demonstrated low cytotoxicity in prostate cancer cells. The attachment of the targeting ligand Tf to AuNPs successfully achieved receptor-mediated cellular uptake in PC-3 cells, a prostate cancer cell line highly expressing Tf receptors. The AuNPs-PEI-FA effectively complexed small interfering RNA (siRNA) through electrostatic interaction. At the cellular level the AuNPs-PEI-FA specifically delivered siRNA into LNCaP cells, a prostate cancer cell line overexpressing prostate specific membrane antigen (PSMA, exhibits a hydrolase enzymic activity with a folate substrate). Following endolysosomal escape the AuNPs-PEI-FA.siRNA formulation produced enhanced endogenous gene silencing compared to the non-targeted formulation. Our results suggest both formulations have potential as non-viral gene delivery vectors in the treatment of prostate cancer.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-07-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2016.05.027PMID 27188645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis

  2016cited by this paper
• RNA interference for multiple myeloma therapy: targeting signal transduction pathways

  2016cited by this paper
• Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer - synthesis, physicochemical characterisation and in vitro evaluation.

  2016cited by this paper
• Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.

  2015cited by this paper
• Knocking down disease: a progress report on siRNA therapeutics

  2015cited by this paper
• Positively charged, surfactant-free gold nanoparticles for nucleic acid delivery

  2015cited by this paper
• Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?

  2015cited by this paper
• Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging.

  2015cited by this paper
• CaCO3/CaIP6 composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth

  2015cited by this paper
• How toxic are gold nanoparticles? The state-of-the-art

  2015cited by this paper
• Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro

  2015cited by this paper
• Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.

  2015cited by this paper
• The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.

  2015cited by this paper
• Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia.

  2014cited by this paper
• Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.

  2014cited by this paper
• Biomolecules-conjugated nanomaterials for targeted cancer therapy.

  2014cited by this paper
• Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer.

  2014cited by this paper
• Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting.

  2014cited by this paper
• Blood protein coating of gold nanoparticles as potential tool for organ targeting.

  2014cited by this paper
• RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.

  2014cited by this paper
• Nanotechnology-based intelligent drug design for cancer metastasis treatment.

  2014cited by this paper
• The role of transcription factors in prostate cancer and potential for future RNA interference therapy

  2014cited by this paper
• Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy.

  2014cited by this paper
• Gold nanoparticles and gold nanoparticle-conjugates for delivery of therapeutic molecules. Progress and challenges.

  2014cited by this paper
• DNA/Fusogenic Lipid Nanocarrier Assembly: Millisecond Structural Dynamics.

  2013cited by this paper
• Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in vitro investigations.

  2013cited by this paper
• Neurotrophin delivery using nanotechnology.

  2013cited by this paper
• In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models.

  2013cited by this paper
• First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.

  2013cited by this paper
• Gold: a versatile tool for in vivo imaging.

  2013cited by this paper
• Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.

  2013cited by this paper
• Protein entrapment in PEGylated lipid nanoparticles.

  2013cited by this paper
• Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells

  2013cited by this paper
• PEGylated gold nanoparticles: polymer quantification as a function of PEG lengths and nanoparticle dimensions

  2013cited by this paper
• Copper-free click chemistry as an emerging tool for the programmed ligation of DNA-functionalised gold nanoparticles.

  2013cited by this paper
• Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.

  2013cited by this paper
• Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?

  2013cited by this paper
• Fluorescein-polyethyleneimine coated gadolinium oxide nanoparticles as T1 magnetic resonance imaging (MRI)–cell labeling (CL) dual agents

  2012cited by this paper
• Highly stable PEGylated gold nanoparticles in water: applications in biology and catalysis

  2012cited by this paper
• Gold nanoparticles as novel agents for cancer therapy.

  2012cited by this paper
• Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

  2012cited by this paper
• Chemical Strategies for the Synthesis of Protein–Polymer Conjugates

  2012cited by this paper
• Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.

  2012cited by this paper
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

  2012cited by this paper
• Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors.

  2012cited by this paper
• Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.

  2011cited by this paper
• Nanoparticle PEGylation for imaging and therapy.

  2011cited by this paper
• Endosomal escape pathways for delivery of biologicals.

  2011cited by this paper
• Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

  2011cited by this paper
• Topology and internal structure of PEGylated lipid nanocarriers for neuronal transfection : synchrotron radiation SAXS and cryo-TEM studies

  2011cited by this paper
• A facile method towards cyclic assembly of gold nanoparticles using DNA template alone.

  2010cited by this paper
• Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.

  2010cited by this paper
• Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles

  2010cited by this paper
• Supramolecular hemoprotein-gold nanoparticle conjugates.

  2010cited by this paper
• Small-molecule delivery by nanoparticles for anticancer therapy.

  2010cited by this paper
• Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.

  2009cited by this paper
• pH-triggered reversible "stealth" polycationic micelles.

  2008cited by this paper
• Targeted drug delivery via folate receptors

  2008cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Size and shape separation of gold nanoparticles with preparative gel electrophoresis.

  2007cited by this paper
• Lipid-based Nanoparticles for Nucleic Acid Delivery

  2007cited by this paper
• Separation of nanoparticles by gel electrophoresis according to size and shape.

  2007cited by this paper
• Effect of the labelling ratio on the photophysics of fluorescein isothiocyanate (FITC) conjugated to bovine serum albumin

  2007cited by this paper
• Size control of gold nanocrystals in citrate reduction: the third role of citrate.

  2007cited by this paper
• Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.

  2005cited by this paper
• Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase

  2005cited by this paper
• Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer.

  2004cited by this paper
• Photothermal Imaging of Nanometer-Sized Metal Particles Among Scatterers

  2002cited by this paper
• Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals

  2000cited by this paper
• Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle.

  1999cited by this paper
• Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo.

  1990cited by this paper

• Formulation and Characterization of Folate Receptor-Targeted Quercetagetin-Loaded Mixed Micelles With Enhanced Oral Bioavailability and Anticancer Efficacy Against Human Prostate Cancer Cells

  2026cites this paper
• Nanosystems Containing Proteins: From Fundamentals to Applications.

  2025cites this paper
• The potential of gold nanoparticles in prostate-specific membrane antigen-targeted radioligand therapy for future treatment of metastatic castration-resistant prostate cancer

  2025cites this paper
• Research on the impact of blood absorption on the photothermal effect of nanoparticles with protein corona.

  2025cites this paper
• Targeted Nanodrug Delivery Strategies for Precision Chemotherapy in Prostate Cancer.

  2025cites this paper
• Impact of protein corona on the optical properties of gold nanoparticles in blood.

  2025cites this paper
• Engineered Extracellular Vesicles for Tumor-Targeted Delivery of Therapeutic siRNA for Lung Cancer Therapy.

  2025cites this paper
• Exploring the dual roles of sec-dependent effectors from Candidatus Liberibacter asiaticus in immunity of citrus plants

  2025cites this paper
• Polymer-based bioconjugation: engineering biomolecules and nanocarriers for advanced applications

  2025cites this paper
• The Landscape of Nanoparticle-based siRNA Delivery and Therapeutic Development.

  2024cites this paper
• In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded 32P-nHA Nanoparticles in Prostate Cancer Therapy

  2023cites this paper
• Unleashing the potential of catalytic RNAs to combat mis-spliced transcripts

  2023cites this paper
• Emerging frontiers in nanomedicine targeted therapy for prostate cancer.

  2023cites this paper
• Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer

  2023cites this paper
• Nanoparticles in Medicine: Current Status in Cancer Treatment

  2023cites this paper
• Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles

  2022cites this paper
• Boosted Radiation Bystander Effect of PSMA-Targeted Gold Nanoparticles in Prostate Cancer Radiosensitization

  2022cites this paper
• Prospects in the use of gold nanoparticles as cancer theranostics and targeted drug delivery agents

  2022cites this paper
• Biomolecule-functionalized nanoformulations for prostate cancer theranostics

  2022cites this paper
• Cellular uptake and cytotoxicity of PEGylated gold nanoparticles in C33A cervical cancer cells

  2022cites this paper
• Water-Soluble Chitosan Conjugated DOTA-Bombesin Peptide Capped Gold Nanoparticles as a Targeted Therapeutic Agent for Prostate Cancer

  2021cites this paper
• NSA_A_301942 69..89

  2021cites this paper
• An overview of antimicrobial and anticancer potential of silver nanoparticles

  2021cites this paper
• Biomacromolecule-Functionalized Nanoparticle-Based Conjugates for Potentiation of Anticancer Therapy.

  2021cites this paper
• A Review on Drug Delivery System for Tumor Therapy

  2021cites this paper
• A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

  2021cites this paper
• The Protein Corona and its Effects on Nanoparticle-Based Drug Delivery Systems.

  2021cites this paper
• Modified gold and polymeric gold nanostructures: Toxicology and biomedical applications

  2021cites this paper
• Therapeutic based on small interfering RNA (siRNA)

  2021cites this paper
• Nanoparticles for Targeting of Prostate Cancer.

  2020cites this paper
• Folate-conjugated nanovehicles: Strategies for cancer therapy.

  2020cites this paper
• Gold Nanoparticles in Conjunction with Nucleic Acids as a Modern Molecular System for Cellular Delivery

  2020cites this paper
• Bifunctional Au-templated RNA nanoparticles enable direct cell uptake detection and GRP75 knockdown in prostate cancer.

  2020cites this paper
• Surface-Initiated Atom Transfer Polymerized Anionic Corona on Gold Nanoparticles for Anti-Cancer Therapy

  2020cites this paper
• Functionalized nano-targeted moieties in management of prostate cancer.

  2020cites this paper
• The cell-penetrating YopM protein-functionalized quantum dot-plasmid DNA conjugate as a novel gene delivery vector.

  2020cites this paper
• Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer

  2020cites this paper
• Active targeting of gold nanoparticles as cancer therapeutics.

  2020cites this paper
• Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy

  2020cites this paper
• Nanomedicine for the Treatment of Advanced Prostate Cancer

  2020cites this paper
• The development of an ultra-sensitive electrochemical immunosensor using a PPyr-NHS functionalized disposable ITO sheet for the detection of interleukin 6 in real human serums

  2020cites this paper
• Gold nanoparticles in delivery applications

  2020cites this paper
• Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells

  2020cites this paper
• Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer

  2019cites this paper
• Structure-function relationships of nonviral gene vectors: Lessons from antimicrobial polymers.

  2019cites this paper
• Nanomedicine for cancer targeted drug delivery, early detection mechanism and therapeutics

  2019cites this paper
• Present Scenario of Bioconjugates in Cancer Therapy: A Review

  2019influential citation
• Nanoscale delivery systems for microRNAs in cancer therapy

  2019cites this paper
• Insights into the Cellular Uptake, Cytotoxicity and Cellular Death Modality of Phospholipid-Coated Gold Nanorods Toward Breast Cancer Cell Lines.

  2019cites this paper
• Multifunctionality of gold nanoparticles: Plausible and convincing properties.

  2019cites this paper
• Key properties of AuNPs for diagnosis and phototherapy Types of AuNPs Colloidal

  2019cites this paper
• Rapid conjugation of nanoparticles, proteins and siRNAs to microbubbles by strain-promoted click chemistry for ultrasound imaging and drug delivery.

  2019cites this paper
• Anisamide‐targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice

  2019influential citation
• Nanocarriers in Different Preclinical and Clinical Stages

  2019cites this paper
• A review of small molecules and drug delivery applications using gold and iron nanoparticles

  2019cites this paper
• Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice

  2019cites this paper
• Engineered Hsp Protein Nanocages for siRNA Delivery.

  2018cites this paper
• Assessment of Charged AuNPs: From Synthesis to Innate Immune Recognition

  2018cites this paper
• Probing the biological obstacles of nanomedicine with gold nanoparticles

  2018cites this paper
• Toxicological status of nanoparticles: What we know and what we don't know.

  2018cites this paper
• Recent Progress in Macromolecule-Anchored Hybrid Gold Nanomaterials for Biomedical Applications.

  2018cites this paper
• Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.

  2018cites this paper
• In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo

  2018cites this paper
• Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer

  2017influential citation
• Therapeutic targeting of non-coding RNAs in cancer.

  2017cites this paper
• Gold nanoparticles enlighten the future of cancer theranostics

  2017cites this paper
• In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer.

  2017cites this paper
• Nanoparticles for death‑induced gene therapy in cancer (Review).

  2017cites this paper
• A SERS investigation of antimicrobial adsorption on silver nanoparticles as mediated by surface modifiers

  2017cites this paper
• Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?

  2017cites this paper
• Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents.

  2017cites this paper
• Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.

  2017cites this paper
• Oestrone‐targeted liposomes for mitoxantrone delivery via oestrogen receptor – synthesis, physicochemical characterization and in‐vitro evaluation

  2017cites this paper
• Recent advances in metal nanoparticles in cancer therapy

  2017cites this paper